Fig. 5From: Evaluation of pneumococcal and tetanus vaccine responses in patients with rheumatoid arthritis receiving baricitinib: results from a long-term extension trial substudyPercentage of patients with a ≥ 2-fold or ≥ 4-fold increase in opsonization index in four serotypes. CI = confidence intervalBack to article page